MAGEA3 and cancer: Furthermore, many approaches have failed, including the melanoma-associated antigen 3 (MAGE-A3) Phase III MA-GRIT study, the largest ever cancer vaccine trial in non-small cell lung cancer (NSCLC) patients [8].